Pharmacokinetics and immediate effects of high-dose carmustine in man
Higby, D.J.
Cancer Treatment Reports 71(4): 433
1987
ISSN/ISBN: 0361-5960 PMID: 3829018 Document Number: 293549
Document emailed within 1 workday
Related Documents
Henner, W.D.; Peters, W.P.; Eder, J.P.; Antman, K.; Schnipper, L.; Frei, E. 1986: Pharmacokinetics and immediate effects of high-dose carmustine in man Cancer Treatment Reports 70(7): 877-880Yamamoto, N.; Yanagi, K.; Matuyama, H.; Shimizu, K.; Mitsui, H.; Shimabukuro, T.; Yamamoto, M.; Sakatoku, J.; Fujita, T.; Matsuoka, K. 1987: Pharmacokinetics of high-dose cisplatin administration (relationship between pharmacokinetics and administration schedule) Hinyokika Kiyo. Acta Urologica Japonica 33(11): 1760-1765
Holthuis, J.J.; de Vries, L.G.; Postmus, P.E.; van Oort, W.W.; Verleun, H.; Hulshoff, A.; Sleijfer, D.T.; Mulder, N.H. 1987: Pharmacokinetics of high-dose teniposide Cancer Treatment Reports 71(6): 599-603
Isacoff, W.H.; Morrison, P.F.; Aroesty, J.; Willis, K.L.; Block, J.B.; Lincoln, T.L. 1977: Pharmacokinetics of high-dose methotrexate with citrovorum factor rescue Cancer Treatment Reports 61(9): 1665-1674
Fasola, G.; Lo Greco, P.; Calori, E.; Zilli, M.; Verlicchi, F.; Motta, M.R.; Ricci, P.; Baccarani, M.; Tura, S. 1991: Pharmacokinetics of high-dose cyclophosphamide for bone marrow transplantation Haematologica 76(2): 120-125
Kergueris, M.F.; Milpied, N.; Moreau, P.; Harousseau, J.L.; Larousse, C. 1994: Pharmacokinetics of high-dose melphalan in adults: influence of renal function Anticancer Research 14(6a): 2379-2382
Morikawa, T.; Kawamura, E. 1989: A method of cisplatin administration with the aid of high-dose bismuth subnitrate, and their pharmacokinetics Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(4 Pt: 2-1): 1094-1098
Rabin, H.R.; Urtasun, R.C.; Partington, J.; Koziol, D.; Sharon, M.; Walker, K. 1980: High-dose metronidazole: pharmacokinetics and bioavailability using an iv preparation and application of its use as a radiosensitizer Cancer Treatment Reports 64(10-11): 1087-1095
Capizzi, R.L.; Yang, J.L.; Rathmell, J.P.; White, J.C.; Cheng, E.; Cheng, Y.C.; Kute, T. 1985: Dose-related pharmacologic effects of high-dose ara-C and its self-potentiation Seminars in Oncology 12(2 Suppl 3: 65-74
Schneider, W.; Bussmann, W.D.; Stahl, B.; Wietschoreck, A.; Kaltenbach, M. 1985: The antianginal efficacy of isosorbide dinitrate: dose-response relation and long-term effects of high-dose treatment Zeitschrift für Kardiologie 74(Suppl 1): 55-63
Milliken, S.; Powles, R.; Jones, A.; Helenglass, G. 1989: Pharmacokinetics of oral fluconazole in autologous bone marrow transplantation recipients given TBI and high-dose melphalan Transplantation Proceedings 21(1 Pt 3): 3067
Pratt, C.B.; Roberts, D.; Shanks, E.C.; Warmath, E.L. 1974: Clinical trials and pharmacokinetics of intermittent high-dose methotrexate-"leucovorin rescue" for children with malignant tumors Cancer Research 34(12): 3326-3331
Weiss, R.B.; Muggia, F.M. 1979: Pulmonary effects of carmustine (bischloroethylnitrosourea, BCNU) Annals of Internal Medicine 91(1): 131-132
Chen, T.L.; Passos-Coelho, J.L.; Noe, D.A.; Kennedy, M.J.; Black, K.C.; Colvin, O.M.; Grochow, L.B. 1995: Nonlinear pharmacokinetics of cyclophosphamide in patients with metastatic breast cancer receiving high-dose chemotherapy followed by autologous bone marrow transplantation Cancer Research 55(4): 810-816
Vree, T.B.; van den Biggelaar-Martea, M.; Verwey-van Wissen, C.P.; Vree, M.L.; Guelen, P.J. 1993: The effects of cimetidine, ranitidine and famotidine on the single-dose pharmacokinetics of naproxen and its metabolites in humans International Journal of Clinical Pharmacology Therapy and Toxicology 31(12): 597-601
Lissoni, P.; Brivio, F.; Brivio, O.; Fumagalli, L.; Gramazio, F.; Rossi, M.; Emanuelli, G.; Alderi, G.; Lavorato, F. 1995: Immune effects of preoperative immunotherapy with high-dose subcutaneous interleukin-2 versus neuroimmunotherapy with low-dose interleukin-2 plus the neurohormone melatonin in gastrointestinal tract tumor patients Journal of Biological Regulators and Homeostatic Agents 9(1): 31-33
Capizzi, R.L.; Powell, B.L. 1987: Sequential high-dose ara-C and asparaginase versus high-dose ara-C alone in the treatment of patients with relapsed and refractory acute leukemias Seminars in Oncology 14(2 Suppl 1: 40-50
Arlin, Z.A.; Feldman, E.J.; Finger, L.R.; Ahmed, T.; Mittelman, A.; Cook, P.; Puccio, C.; Baskind, P.; Arnold, P.; Razis, E.D. 1991: Short course high dose mitoxantrone with high dose cytarabine is effective therapy for adult lymphoblastic leukemia Leukemia 5(8): 712-714
Smith, R.J.; Sweetenham, J.W. 1995: A mononuclear cell dose of 3 x 10(8)/kg predicts early multilineage recovery in patients with malignant lymphoma treated with carmustine, etoposide, Ara-C and melphalan (BEAM) and peripheral blood progenitor cell transplantation Experimental Hematology 23(14): 1581-1588
Colpaert, F.C.; Janssen, P.A. 1982: Factors regulating drug cue sensitivity: the effects of dose ratio and absolute dose level in the case of fentanyl dose-dose discrimination Archives Internationales de Pharmacodynamie et de Therapie 258(2): 283-299